Medable Secures $25M Venture Funding to Drive Global Adoption of Decentralized Clinical Trials

Written By Patrick Jolicoeur

Medable, Inc., the leading global platform for decentralized clinical trials, today announced $25 million in funding to accelerate clinical drug development with digital technology, enabling effective new therapies to reach patients faster.

Read more here:

https://www.businesswire.com/news/home/20200504005198/en/Medable-Secures-25M-Venture-Funding-Drive-Global

Patrick Jolicoeur
Previous

A modernized 'butler bell': How a virtual bedside assistant can better help patients
Next

Press Ganey Acquires NarrativeDx; Expands Ability to Provide Consumer Insights